MATINAS BIOPHARMA HOLDINGS, INC. Payments of Merger Related Costs, Financing Activities
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Payments of Merger Related Costs, Financing Activities of $0 for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities · last filed 2016-11-14
- 2016-09-30: Payments of Merger Related Costs, Financing Activities 9 month $0.00.
- 2015-09-30: Payments of Merger Related Costs, Financing Activities 9 month $61.95K.
| Period end | Payments of Merger Related Costs, Financing Activities 9 month |
|---|---|
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 |
| 2015-09-30 | $61.95K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |